Patient engagement is a necessity when performing health technology assessment to help better assess and identify the outcomes of a rare disease.

The National Comprehensive Cancer Network (NCCN)-;an alliance of leading cancer centers focusing on maintaining evidence-based expert consensus driven guidelines for care-;announces the publication of ...

According to a new market research report, 'Minimal Residual Disease Testing Market Size, Share, Forecast, & Trends Analysis By ...

Immunovia , the pancreatic cancer diagnostics company, will present an update on its next-generation test at the annual meeting of the PRECEDE Consortium, a collaboration of 51 pancreatic centers ...

When a woman has breast cancer, her treatment may include a mastectomy with lymph node removal along with radiation therapy.

Clinical trials play a pivotal role in the development and evaluation of new medical ... promoting better patient outcomes and advancing medical science. PharmiWeb.com is Europe's leading ...

By Colin Moynihan A hearing has been scheduled for next week for a judge to decide whether Mickey Barreto, who stayed at the New Yorker Hotel in Manhattan, should be held in a hospital for ...

Targeted therapy revolutionized cancer treatment, with gene fusions leading the way when the FDA approved imatinib in 2001 to ...

and online resources through which a dental practitioner can acquire all information about the latest trends and best ...

In September, the nation reached a major milestone when the Treasury Department announced that 50 million Americans have ...

The life science group Sartorius has released its second edition of the “High-Throughput Screening (HTS) by Cytometry” handbook, tailored to support new and experienced researchers who use flow ...